Examining the basic principles of quality by design (QbD) approach in analytical studies

Yıl 2021, Cilt: 51 Sayı: 2, 272 - 276, 31.08.2021

Burcu Mesut Cem Önal Buket Aksu Yıldız Özsoy

Öz

Although the first application of Quality by Design (QbD) concept started for product development studies, the number of studies regarding its application to analytical development has been increased recently. Basically, QbD strategy in both formulation development and analytic studies are identical logically and conceptually, but they have somedifferences in terms of its terminology and application. Essential terminology and approach differences in this concept are; the determination of the analytic target profile, critical method characteristics, critical process parameters, and the determination of the method study area. However, the risk evaluation method which is necessary for the appropriate application of quality by design is also an inseparable part of the analytical quality by design. Despite those terminological differences, developing a qualitybased method with the analytical design that contributes to research with an appropriately applied risk-based design quality approach and provides multiple advantages that will be noticed each and every time, will be useful both for researchers and authorities who investigate license documentation and changes. Therefore, the terminology which is used for analytic quality by design and appropriate risk evaluation approaches are explained in this study.

Anahtar Kelimeler

Analitycal quality by design, risk assesment, process analytical technology, analytical target profile, critical quality atrributes

Kaynakça

• • Abdel-Moety, E. M., Rezk, M. R., Wadia, M., & Tantawy, M. A. (2021). A combined approach of green chemistry and quality-by-design for sustainable and robust analysis of two newly introduced pharmaceutical formulations treating benign prostate hyperplasia. Microchemical Journal, 160(B). doi: 10.1016/j.microc.2020.105711
• • Aksu, B. (2013). İlaçta Kalite Tasarımı (QbD) ve İlgili Yasal Düzenlemeler (1th ed.). Istanbul, Turkey: Neta Reklam Tanıtım Matbaacılık San. Ve Tic. Ltd. Şti.
• • Aksu, B. (2015). Tasarımla kalite (Quality By Design: QbD) ve kalite risk yönetimi. Marmara Pharmaceutical Journal, 19, 12-18. doi:10.12991/mpj.2015198605
• • Aksu, B., & Mesut, B. (2015). Quality by design (QbD) for pharmaceutical area. Journal of Faculty of Pharmacy, 45(2), 233-251.
• • Amri (2019). Process analytical technology and pharmaceutical quality by design. Retrieved from https://www.amriglobal.com/ solutions/analytical-services/solid-state-chemistry-and-particleengineering/ pat-and-pharmaceutical-quality-by-design/
• • Argentine, M., Barnet, K., Chatfield, M., Hewitt, E., Jackson, P., Karmarkar, S. & Zhao, Y. (2017). Evaluating progress in analytical quality by design. pharmaceutical technology, 41(4). Retrieved from http://www.pharmtech.com/evaluating-progress-analyticalquality- design
• • Chatterjee, S. (2013). QbD considerations for analytical methods - FDA Perspective. Retrieved from http://qbdworks.com/wp-content/ uploads/2014/06/AnalyticalQbDIFPAC.pdf • ICHQ8. (2014). ICH guideline Q8 (R2) on pharmaceutical development. European Medicines Agency.
• • ICHQ9. (2015). ICH guideline Q9 on quality risk management. European Medicines Agency.
• • Kopp, J., Zauner, F. B., Pell, A., Hausjel, A., Humer, D., Ebner, J., Herwig, C., Spadiut, O., Slouka, C., & Pell, R. (2020). Development of a generic reversed-phase liquid chromatography method for protein quantification using analytical quality-by-design principles. Journal of Pharmaceutical and Biomedical Analysis. 188, doi: 113412.
• • LoBrutto, R. (2013). Analytical quality by design in the pharmaceutical industry. Retrieved from http://www.chromatographyonline. com/analytical-quality-design-pharmaceutical-industry • Mosford, K. (2018). The benefits of aqbd. The Column, 14, 9-11.
• • Nompari, L., Orlandini, S., Pasquini, B., Campa, C., Rovini, M., Del Bubba, M., & Furlanetto, S. (2018). Quality by design approach in the development of an ultra-high-performance liquid chromatography method for bexsero meningococcal group b vaccine. Talanta, 178, 552-562. doi:10.1016/j.talanta.2017.09.077
• • Patwardhan, K., Asgarzadeh, F., Dassinger, T., Albers, J., & Repka, M. A. (2015). A quality by design approach to understand formulation and process variability in pharmaceutical melt extrusion processes. Journal of Pharmacy and Pharmacology, 67(5), 673-684. doi:10.1111/jphp.12370
• • Peraman, R., Bhadraya, K., & Padmanabha Reddy, Y. (2015a). Analytical quality by design: a tool for regulatory flexibility and robust analytics. International Journal of Analytical Chemistry, 2015, 868727. doi:10.1155/2015/868727
• • Peraman, R., Bhadraya, K., Reddy, Y. P., Reddy, C. S., & Lokesh, T. (2015b). Analytical quality by design approach in RP-HPLC method development for the assay of etofenamate in dosage forms. Indian Journal of Pharmaceutical Sciences , 77(6), 751-757. doi:10.4103/0250-474x.174971
• • Rao, G., Moreira, A., & Brorson, K. (2009). Disposable bioprocessing: The future has arrived. Biotechnology and Bioengineering.102(2), 348-356. doi:10.1002/bit.22192
• • Reid, G. L., Morgado, J., Barnett, K., Harrington, B., Wang, J., Harwood, J., & Fortin, D. (2013). Analytical quality by design (AQbD) in pharmaceutical development. American Pharmaceutical Review, Retrieved from https://www.americanpharmaceuticalreview. com/Featured-Articles/144191-Analytical-Quality-by-Design- AQbD-in-Pharmaceutical-Development/
• • Sangshetti, J. N., Deshpande, M., Zaheer, Z., Shinde, D. B., & Arote, R. (2017). Quality by design approach: Regulatory need. Arabian Journal of Chemistry, 10, 3412-3425. doi:10.1016/j.arabjc. 2014.01.025 • Tang, Y. (2011). Quality by design approaches to analytical methods. FDA. Retrieved from https://www.fda.gov/media/84046/ download
• • Zacharis, C. K., & Vastardi, E. (2018). Application of analytical quality by design principles for the determination of alkyl p-toluenesulfonates impurities in aprepitant by HPLC. Validation using totalerror concept. Journal of Pharmaceutical and Biomedical Analysis, 150, 152-161. doi:https://doi.org/10.1016/j.jpba.2017.12.009
• • Zhang, L. & Mao, S. (2017). Application of quality by design in the current drug development. Asian Journal of Pharmaceutical Sciences, 12(1), 1-8. doi:10.1016/j.ajps.2016.07.006